Dabur India Ltd

The provided transcript and pages from the Dabur India Limited Q4 and FY23 results call do not contain specific information regarding the current or expected order book or any details about pending orders. The discussion primarily focuses on: - Stock returns and inventory management (stock takeback around Rs. 20 crores per quarter). - Product culling and handling of slow-moving SKUs. - Growth expectations and portfolio mix (Foods at ~20%, Healthcare ~30%, HPC ~50%). - Distribution reach and new product placements. - Margin pressures and expense items. - Market share movements and category growth. - Inflation and supply chain challenges. No direct mention or quantitative data about order books or pending orders is available on the referenced pages.

The document does not mention any current or planned fundraising through debt or equity. Key points related to financials and investments include: - Mohit Malhotra and Ankush Jain discuss capital investments mainly for business expansion (e.g., Rs. 90 crores investment in Nepal for juice capacity). - There is no indication of new equity or debt fundraising plans. - Discussions revolve around business growth, distribution expansion, and cost optimization rather than raising fresh funds. - Existing financial management includes controlling expenses, media investments, and reshaping distribution but no mention of tapping markets for funding. Therefore, as per the information on the 27 pages of this document, no new debt or equity fundraising is currently planned or announced.

- Dabur has an enabling approval from the Nepal government for a capital investment of NPR 900 crores over 5-6 years to expand capacity, particularly in juices. - For the current year, the planned investment in Nepal is around Rs. 90 crores to address increasing demand and capacity shortfall in juices. - The company is focusing on efficiencies in manufacturing, warehousing, and indirect overheads as part of their Samriddhi program for cost management. - Dabur is engaged in culling non-performing SKUs (around 180 SKUs culled in last 6 months) and rationalizing investments, focusing capital and marketing behind 8 core "power brands" for sustainable growth. - Media investments have been increased (in India by 15%) with a target to raise overall media spends to 7%-8% to support brand growth, implying strategic capital allocation in marketing.

- Foods and Beverage vertical aims to double from Rs. 1,700 crores to Rs. 4,000-5,000 crores in 5-6 years (18-19% growth). - Drinks segment (juices, nectars, fizz) grew from Rs. 200 crores (annual) with an exit run rate around Rs. 300 crores, targeting Rs. 500 crores in next 2-3 years. - Badshah Foods business targets 20% growth next year, scaling Rs. 400 crores to Rs. 500 crores, aiming Rs. 1,000 crores in 5 years. - Overall consolidated revenue crossed Rs. 11,530 crores with 8.2% constant currency growth; India business 6.2%, international 11.1%. - Healthcare growth expected flattish in short-term post-COVID but focus remains on core brands and portfolio diversification. - HPC 3-year CAGR near 10%; recent growth slower but steady recovery expected. - Emphasis on expanding direct distribution (currently 15-20% of reach to 1.4 million outlets) to boost volume growth. - New Product Development (NPD) contributes ~7% of e-commerce business, showing promising growth.

- Dabur aims to improve gross margins gradually as 6%-6.5% inflation is being matched by equivalent price increases (Page 22). - Operating margin was 18.8% in FY23; target is to increase it to around 19%-19.5% in FY24, with potential to inch towards 20% over 1-2 years balancing media spends (Pages 14, 22). - Media spends are planned to increase from ~5.5% to 7%-8% of revenue, indicating reinvestment of margin gains into growth drivers (Page 17). - Food & Beverage business targets high single-digit to double-digit growth, aiming to double in size (~18%-19% CAGR over 5 years) (Pages 9, 11). - Healthcare expected to see strong growth going forward after COVID base normalization; HPC growth was ~5% in current year with past 3-year CAGR near 10% (Pages 13, 5). - International business grew 11% in constant currency; distribution changes and margin improvements are underway (Pages 17, 4). - Overall, consistent focus on driving volume growth, market penetration, and expanding core brands supports positive earnings trajectory.